These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12882925)

  • 1. Vascular endothelial function and blood pressure homeostasis in mice overexpressing IGF binding protein-1.
    Wheatcroft SB; Kearney MT; Shah AM; Grieve DJ; Williams IL; Miell JP; Crossey PA
    Diabetes; 2003 Aug; 52(8):2075-82. PubMed ID: 12882925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low circulating levels of insulin-like growth factor binding protein-1 (IGFBP-1) are closely associated with the presence of macrovascular disease and hypertension in type 2 diabetes.
    Heald AH; Siddals KW; Fraser W; Taylor W; Kaushal K; Morris J; Young RJ; White A; Gibson JM
    Diabetes; 2002 Aug; 51(8):2629-36. PubMed ID: 12145180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of the insulin/IGF binding protein-1 axis in transgenic mice is associated with hyperinsulinemia and glucose intolerance.
    Crossey PA; Jones JS; Miell JP
    Diabetes; 2000 Mar; 49(3):457-65. PubMed ID: 10868969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of gender on basal and insulin-like growth factor I-regulated nitric oxide synthase activity in adult rat left ventricular myocytes.
    Esberg LB; Zhang X; Scott GI; Culver B; Ren J
    Comp Biochem Physiol A Mol Integr Physiol; 2004 Jun; 138(2):141-6. PubMed ID: 15275648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular insulin-like growth factor-I resistance and diet-induced obesity.
    Imrie H; Abbas A; Viswambharan H; Rajwani A; Cubbon RM; Gage M; Kahn M; Ezzat VA; Duncan ER; Grant PJ; Ajjan R; Wheatcroft SB; Kearney MT
    Endocrinology; 2009 Oct; 150(10):4575-82. PubMed ID: 19608653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor and transforming growth factor-beta1 regulate the expression of insulin-like growth factor-binding protein-3, -4, and -5 in large vessel endothelial cells.
    Dahlfors G; Arnqvist HJ
    Endocrinology; 2000 Jun; 141(6):2062-7. PubMed ID: 10830291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein expression, vascular reactivity and soluble guanylate cyclase activity in mice lacking the endothelial cell nitric oxide synthase: contributions of NOS isoforms to blood pressure and heart rate control.
    Kojda G; Laursen JB; Ramasamy S; Kent JD; Kurz S; Burchfield J; Shesely EG; Harrison DG
    Cardiovasc Res; 1999 Apr; 42(1):206-13. PubMed ID: 10435012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations.
    Heald AH; Cruickshank JK; Riste LK; Cade JE; Anderson S; Greenhalgh A; Sampayo J; Taylor W; Fraser W; White A; Gibson JM
    Diabetologia; 2001 Mar; 44(3):333-9. PubMed ID: 11317665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
    Heald A; Kaushal K; Anderson S; Redpath M; Durrington PN; Selby PL; Gibson MJ
    Gynecol Endocrinol; 2005 Mar; 20(3):176-82. PubMed ID: 16019358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel role of the IGF-1 receptor in endothelial function and repair: studies in endothelium-targeted IGF-1 receptor transgenic mice.
    Imrie H; Viswambharan H; Sukumar P; Abbas A; Cubbon RM; Yuldasheva N; Gage M; Smith J; Galloway S; Skromna A; Rashid ST; Futers TS; Xuan S; Gatenby VK; Grant PJ; Channon KM; Beech DJ; Wheatcroft SB; Kearney MT
    Diabetes; 2012 Sep; 61(9):2359-68. PubMed ID: 22733797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabolic syndrome and insulin-like growth factor I regulation in adolescent obesity.
    Attia N; Tamborlane WV; Heptulla R; Maggs D; Grozman A; Sherwin RS; Caprio S
    J Clin Endocrinol Metab; 1998 May; 83(5):1467-71. PubMed ID: 9589640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver-specific expression of human insulin-like growth factor binding protein-1 in transgenic mice: repercussions on reproduction, ante- and perinatal mortality and postnatal growth.
    Gay E; Seurin D; Babajko S; Doublier S; Cazillis M; Binoux M
    Endocrinology; 1997 Jul; 138(7):2937-47. PubMed ID: 9202238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor binding protein (IGFBP-1) involvement in intrauterine growth retardation: study on IGFBP-1 overexpressing transgenic mice.
    Ben Lagha N; Seurin D; Le Bouc Y; Binoux M; Berdal A; Menuelle P; Babajko S
    Endocrinology; 2006 Oct; 147(10):4730-7. PubMed ID: 16809446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of endothelial nitric oxide synthase promotes endothelin-induced hypertension: lessons from endothelin-1 transgenic/endothelial nitric oxide synthase knockout mice.
    Quaschning T; Voss F; Relle K; Kalk P; Vignon-Zellweger N; Pfab T; Bauer C; Theilig F; Bachmann S; Kraemer-Guth A; Wanner C; Theuring F; Galle J; Hocher B
    J Am Soc Nephrol; 2007 Mar; 18(3):730-40. PubMed ID: 17287431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of total insulin-like growth factor-I, insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke.
    Kaplan RC; McGinn AP; Pollak MN; Kuller LH; Strickler HD; Rohan TE; Cappola AR; Xue X; Psaty BM
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1319-25. PubMed ID: 17264182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto-maternal interface.
    Han VK; Bassett N; Walton J; Challis JR
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2680-93. PubMed ID: 8675597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures.
    Benbassat CA; Maki KC; Unterman TG
    J Clin Endocrinol Metab; 1997 May; 82(5):1484-91. PubMed ID: 9141538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome.
    Heald AH; Kaushal K; Siddals KW; Rudenski AS; Anderson SG; Gibson JM
    Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):371-6. PubMed ID: 16915540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of oral glucose on serum free insulin-like growth factor-I and -II in health adults.
    Frystyk J; Grøfte T; Skjaerbaek C; Orskov H
    J Clin Endocrinol Metab; 1997 Sep; 82(9):3124-7. PubMed ID: 9284756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal biopterin metabolism is a major cause of impaired endothelium-dependent relaxation through nitric oxide/O2- imbalance in insulin-resistant rat aorta.
    Shinozaki K; Kashiwagi A; Nishio Y; Okamura T; Yoshida Y; Masada M; Toda N; Kikkawa R
    Diabetes; 1999 Dec; 48(12):2437-45. PubMed ID: 10580434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.